COVID-19 infection is treated with globally recommended medicines/drugs that are said to be effective.
The only two methods to survive the COVID-19 pandemic are prevention and prudence. While wearing masks and following correct sanitization procedures are necessary to keep the coronavirus at bay, using treatments and medicines to treat the infection is also necessary.
Last Monday, the World Health Organization (WHO) approved two new medications to treat COVID-19 infection. As a result, a number of drugs to treat COVID-19 infection have been licensed around the world.
Medications' efficacy against COVID-19 infection
Despite the fact that prophylactic methods are efficient in preventing the virus from spreading, pharmaceuticals and medicines are required to counteract the virus's effects on a person who acquires it. Vaccines are thought to be the most effective weapon against the virus thus far. Many groups, however, do not have access to it. "Vaccination is having a significant impact on case counts and hospitalizations in a few of high-income countries," the WHO notes, "but barriers to global vaccination access mean that many people remain vulnerable." "Even in vaccinated individuals, there are questions about the duration of protection and efficacy of current vaccines – as well as the efficacy of existing COVID-19 therapies – against developing SARS-CoV-2 variants," the report continues.
Medicines for COVID-19 have been recommended by the WHO.
In its most recent assessment, the WHO examined and recommended the following medications as effective COVID-19 treatments: Sotrovimab, Casirivimab-imdevimab, Tocilizumab, or Sarlumab, Baricitinib, Ruxolitinib, and Tofacitinib, Sotrovimab, Casirivimab-imdevimab, Tocilizumab, or Sarlumab
While the WHO's Guideline Development Group (GDG) strongly recommends Baricitinib, Tocilizumab or sarlumab, and Systemic corticosteroids, other drugs like ruxolitinib and tofacitinib, sotrovimab, and casirivimab-imdevimab have conditional recommendations, meaning they can be recommended as a substitute or only in certain circumstances.
Drugs to avoid for treating COVID-19
Ivermectin, Hydroxychloroquine, Lopinavir/ritonavir, and Remdesivir have all been strongly advised against being used in the treatment of COVID. These medications do not qualify to be used for COVID treatment due to a lack of data on their effectiveness in reducing mortality, hospitalization needs, and other considerations. However, only a few of these medications have been approved for clinical studies. "When there is extremely low certainty evidence and future research offers a significant potential for reducing ambiguity regarding the effects of the intervention at a reasonable cost," the WHO notes.
He follows the WHO's recommendations for youngsters. Significant COVID-19 infection in children is defined by symptoms such as severe chest wall in-drawing, grunting, central cyanosis, or the presence of any other general danger signals such as difficulty to breastfeed or drink, lethargy, convulsions, or a lowered level of awareness.
Read More Breathlessness caused by 'Long COVID' could indicate heart damage
Casirivimab and imdevimab have been recommended by the WHO for use in children. "Only a small number of children become critically ill as a result of COVID-19. Those who do and are seronegative may benefit from Casirivimab and imdevimab, respectively "It declares.
For expert advice at just Rs 100/- click here
Comments
Write your first comment.